Showing 3,661 - 3,680 results of 18,438 for search 'significantly ((((((we decrease) OR (largest decrease))) OR (a decrease))) OR (mean decrease))', query time: 0.58s Refine Results
  1. 3661
  2. 3662
  3. 3663
  4. 3664
  5. 3665
  6. 3666
  7. 3667
  8. 3668
  9. 3669
  10. 3670
  11. 3671
  12. 3672
  13. 3673

    Raw data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  14. 3674

    Data. by Saeedeh Abbasi (9423189)

    Published 2025
    “…However, both groups exhibited a significant decrease in CCI during prolonged standing (time *  condition: p =  0.003). …”
  15. 3675

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  16. 3676

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  17. 3677

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  18. 3678

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  19. 3679
  20. 3680